You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

Guidelines & Advice
About Guidelines Email Guidelines Team

Patient Safety Issues: Key Components of Intravenous Systemic Cancer Therapy Labelling

Version: 2 ID: 12-11 Apr 2023
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
M. Trudeau, E. Green, R. Cosby, F. Charbonneau, T. Easty, Y. Ko, P. Marchand, D. U, N. Berger, S. Hertz, Chemotherapy Labelling Panel

Intended Guideline Users

Healthcare professionals who prescribe, prepare, or administer intravenous chemotherapy, including medical oncologists, pharmacists, pharmacy technicians, and oncology nurses, as well as designers of prescription label software, patient safety directors in organizations, administrators of hospitals, and community access care organizations.

Research Question(s)

What are the necessary components and formatting of a chemotherapy label to maximize safe delivery and minimize errors? Chemotherapy labels associated with the delivery of a dose of intravenous chemotherapy are of particular interest.

pdf download Summary (PDF) (380.59 KB)
pdf download Full Report (PDF) (1.36 MB)